Triad Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,225
Closed -$268K 36
2026
Q1
$268K Hold
2,225
0.32% 36
2025
Q4
$234K Buy
+2,225
New +$209K 0.24% 35
2024
Q1
$353K Hold
2,675
0.43% 32
2023
Q4
$292K Hold
2,675
0.38% 35
2023
Q3
$275K Hold
2,675
0.4% 36
2023
Q2
$309K Hold
2,675
0.43% 39
2023
Q1
$285K Hold
2,675
0.41% 40
2022
Q4
$297K Hold
2,675
0.46% 41
2022
Q3
$230K Hold
2,675
0.4% 43
2022
Q2
$244K Hold
2,675
0.36% 53
2022
Q1
$219K Hold
2,675
0.21% 56
2021
Q4
$205K Buy
+2,675
New +$213K 0.19% 59
2020
Q4
$219K Hold
2,803
0.24% 46
2020
Q3
$222K Hold
2,803
0.31% 41
2020
Q2
$207K Hold
2,803
0.28% 43
2020
Q1
$206K Hold
2,803
0.36% 38
2019
Q4
$243K Sell
2,803
-326
-10% -$26.8K 0.24% 43
2019
Q3
$242K Buy
3,129
+116
+4% +$9.3K 0.26% 43
2019
Q2
$241K Sell
3,013
-115
-4% -$8.8K 0.25% 43
2019
Q1
$248K Buy
3,128
+115
+4% +$8.6K 0.25% 48
2018
Q4
$221K Buy
+3,013
New +$213K 0.29% 48

Other funds holding MRK

Triad Investment Management's MRK Position: Q2 2026 in Review

Triad Investment Management sold out of Merck (MRK) in Q2 2026, closing a stake of 2,225 shares — an estimated $268K sold.

Triad Investment Management first reported a position in MRK in Q4 2018 and held it in 21 quarters. The position peaked at $353K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Triad Investment Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Triad Investment Management sold 2,225 Merck shares in Q2 2026, an estimated $268K.
  • Triad Investment Management first reported a position in Merck in Q4 2018 and held it in 21 quarters.
  • Triad Investment Management's Merck position peaked at $353K in Q1 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Triad Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.